Doctor profile · Federal record

Dr. Spandana Brown, M.D.

Endocrinology, Diabetes & Metabolism Physician (CMS: Endocrinology) · Internal Medicine Physician · Houston, TX

  • NPI 1255710802
  • Accepts Medicare
  • 11 yrs in practice
  • Female
  • Group practice
  • No sanctions

Practice & contact

Operates at 2 locations .

NPPES Updated May 11, 2026
Primary practice
4191 Bellaire Blvd Ste 250
Houston, TX 770251017
(346) 356-7000
Additional location
6565 Fannin St.
Houston, TX 77030
(713) 441-1577
Mailing address
1410 Meadow Glade Court
Sugar Land, TX 77479

Credentials & registration

NPPES · NUCC
NPI registered
May 2015 — 11 yrs on file
Profile last updated
August 3, 2022
Year of graduation
2015 — 11 yrs since
Specialty taxonomy
207RE0101X — NUCC code
State licenses (2)
Texas #S4447 · Texas #BP10053916

Federal sanctions & exclusions

OIG LEIE Updated May 11, 2026

No sanctions, exclusions or revocations on file

Checked against OIG LEIE on NPI 1255710802. Last verified May 11, 2026.

Medicare procedures · 2023

Top services delivered

CMS Provider Utilization
Total services
23,058
Distinct HCPCS
10
Medicare allowed
$392,880
HCPCS Description Services Patients Avg allowed
J3111 Injection, romosozumab-aqqg, 1 mg 16,380 18 $10
J0897 Injection, denosumab, 1 mg 5,580 63 $23
99214 Established patient office or other outpatient visit, 30-39 minutes 348 255 $129
96372 Injection of drug or substance under skin or into muscle 171 79 $14
95251 Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report 89 45 $35
99215 Established patient office or other outpatient visit, 40-54 minutes 88 58 $180
83036 Hemoglobin a1c level 79 61 $9
99205 New patient office or other outpatient visit, 60-74 minutes 72 72 $221
J3489 Injection, zoledronic acid, 1 mg 65 13 $8
99204 New patient office or other outpatient visit, 45-59 minutes 64 64 $169

In context: peer comparison

Among 59 peers in this city , average services per provider: 198. This provider delivers 116× the peer median.

Open Payments

Industry payments received

CMS Open Payments
All-time total
$1,045
Transactions
50
Manufacturers
15
Payer (manufacturer) Industry Txns Amount
Novo Nordisk Inc 9 $175.29
Lilly USA, LLC 9 $157.60
Radius Health, Inc. 4 $100.46
ABBVIE INC. 5 $94.90
Abbott Laboratories 4 $87.36
SANOFI-AVENTIS U.S. LLC 3 $78.91
Amgen Inc. 5 $71.37
PFIZER INC. 2 $63.75
AstraZeneca Pharmaceuticals LP 2 $36.66
IBSA Pharma Inc. 2 $31.86
Dexcom, Inc. 1 $23.51
Alexion Pharmaceuticals, Inc. 1 $21.35
Boehringer Ingelheim Pharmaceuticals, Inc. 1 $17.80
CeQur Corporation 1 $17.60
Exact Sciences Corporation 1 $17.51

By nature of payment

Food and Beverage
$1,045

Medicare Part D · 2023

Top prescriptions

CMS Part D Prescriber
Total claims
1,744
Patients
509
Total drug cost
$1,389,156
Drug Type Claims Patients Total cost
Levothyroxine Sodium Generic 261 85 $3,814
Ozempic (Semaglutide) Brand 253 60 $434,850
Tresiba Flextouch U-100 (Insulin Degludec) Brand 165 51 $98,115
Trulicity (Dulaglutide) Brand 163 41 $270,876
Nano 2nd Gen Pen Needle (Pen Needle, Diabetic) Brand 135 48 $10,237
Metformin Hcl Generic 125 40 $1,065
Jardiance (Empagliflozin) Brand 112 30 $134,353
Repaglinide Generic 84 26 $5,224
Methimazole Generic 74 23 $1,004
Farxiga (Dapagliflozin Propanediol) Brand 73 17 $88,581

Hospital affiliations

CMS Hospital Compare

Frequently asked questions

Auto-generated from federal data
What is Dr. Spandana Brown's medical specialty?
Dr. Spandana Brown practices Endocrinology, Diabetes & Metabolism Physician in Houston, TX.
Where does Dr. Spandana Brown practice?
Dr. Spandana Brown practices at 4191 Bellaire Blvd Ste 250, Houston, TX 770251017. Office phone: 3463567000.
What is Dr. Spandana Brown's NPI?
Dr. Spandana Brown's National Provider Identifier (NPI) is 1255710802, issued by NPPES.
Does Dr. Spandana Brown accept Medicare assignment?
Yes. Dr. Spandana Brown accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Spandana Brown commonly perform?
Top Medicare-reported procedures in 2023: Injection, romosozumab-aqqg, 1 mg (HCPCS J3111); Injection, denosumab, 1 mg (HCPCS J0897); Established patient office or other outpatient visit (HCPCS 99214). Source: CMS Medicare Physician & Other Practitioners file.